In breast cancers, PI3K-AktmTOR-S6K1signaling pathway is often hyperactive due to overexpression of genes encoding growth factors or estrogen receptors, constitutive activation of PI3K or Akt and loss of phosphatase and tensin homolog (PTEN), a negative regulator of this pathway. Here, ESR1 is linked to breast carcinoma.